Trends in sexual behaviour and the incidence of sexually transmitted diseases and HIV among drug-using prostitutes, Amsterdam 1986-1992. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Trends in sexual behaviour and the incidence of sexually transmitted diseases and HIV among drug-using prostitutes, Amsterdam 1986-1992.

AIDS. 1994 Feb;8(2):213-21. Unique Identifier : AIDSLINE MED/94318205
van Ameijden EJ; van den Hoek AJ; van Haastrecht HJ; Coutinho RA; Municipal Health Service, Department of Public Health and; Environment, Amsterdam, The Netherlands.


Abstract: OBJECTIVE: To determine trends in commercial sexual risk behaviour among drug-using prostitutes in Amsterdam after local and national prevention campaigns began in 1987. DESIGN: A subgroup of 281 drug-using prostitutes was selected from a comprehensive, open cohort study of drug users in Amsterdam. METHODS: Cross-sectional (at intake) and within-person trends in sexual behaviour were evaluated. Person-time analysis was used to determine trends in incidence of sexually transmitted disease (STD). RESULTS: From 1986 to 1992, 'always' use of condoms in the 6 months preceding intake increased from 21 to 58% (P < 0.001) and the number of commercial contacts declined from 84 to 64 per month (P = 0.06). Consequently, the mean number of unprotected commercial contacts declined from 26 to nine per month (P < 0.001). Temporal trends within individual prostitutes from visits 1 to 8 (mean interval between visits, 4 months) showed a somewhat larger risk reduction than the cross-sectional trends. From 1989 to 1992, the STD incidence declined from 61 to 40 episodes per 100 person-years (P = 0.06). Prostitutes residing in Amsterdam for shorter time periods reported more STD and a relatively small core group reported the majority of STD episodes. At intake, when < 10% of all participants knew their HIV serostatus, HIV-positive prostitutes reported significantly lower levels of condom use and more STD than HIV-negatives, while, after learning their serostatus, levels of condom use and the STD-incidence were comparable. Prevalent and incident HIV infections were not observed among non-injecting prostitutes. CONCLUSIONS: Drug-using prostitutes have reduced sexual risk behaviour. There is evidence for the effectiveness of HIV testing and counseling. At present, new infections among clients of drug-using prostitutes are expected to occur, although not on a large scale. Since the incidence of STD continues to be high, it is important to monitor the spread of HIV among heterosexuals, including prostitutes and their clients, closely.
Keywords: Adult Cocaine Cohort Studies Comorbidity Condoms/*UTILIZATION Cross-Sectional Studies Female Follow-Up Studies Germany/ETHNOLOGY Heroin Dependence/EPIDEMIOLOGY/PREVENTION & CONTROL Human HIV Infections/*EPIDEMIOLOGY/PREVENTION & CONTROL HIV Seroprevalence Incidence Netherlands/EPIDEMIOLOGY Program Evaluation Prostitution/*STATISTICS & NUMER DATA Sex Behavior/*STATISTICS & NUMER DATA Sexually Transmitted Diseases/*EPIDEMIOLOGY Substance Abuse/*EPIDEMIOLOGY Substance Abuse Treatment Centers Substance Abuse, Intravenous/EPIDEMIOLOGY Support, Non-U.S. Gov't Urban Population JOURNAL ARTICLE

KWDadultcocainecohortstudiescomorbiditycondoms/KWDutilizationcross-sectionalstudiesfemalefollow-upstudiesgermany/ethnologyheroindependence/epidemiology/prevention&controlhumanhivinfections/KWDepidemiology/prevention&controlhivseroprevalenceincidencenetherlands/epidemiologyprogramevaluationprostitution/KWDstatistics&numerdatasexbehavior/KWDstatistics&numerdatasexuallytransmitteddiseases/KWDepidemiologysubstanceabuse/KWDepidemiologysubstanceabusetreatmentcenterssubstanceabuse,intravenous/epidemiologysupport,non-uKWDsKWDgov'turbanpopulationjournalarticle
941130
M94B0772


Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .